Several substituted-quinazolin-3(4H)-ones 8-11ad were synthesized by condensation of 2-chloro-N-(4-oxosubstituted-quinazolin-3(4H)-yl)-acetamides with various substituted imidazoles through one pot reaction. Elemental analysis, IR, 1 H-NMR and mass spectral data confirmed the structure of the newly synthesized compounds. Synthesized quinazolin-4-one derivatives were investigated for their antitubercular, antibacterial and antifungal activities. Some of the tested compounds showed good antitubercular activity. None of the synthesized compounds showed significant antibacterial and antifungal activity.
Quinazolin-4-one ring system has been consistently rewarded as a promising molecule because of its broad spectrum pharmacological activities like antitubercular, 1) antibacterial, 2) antifungal, 3) anticancer, 4, 5) anti-HIV, 6) anthelmintic, 7) anti-inflammatory 8) and antihypertensive activities. 9) Imidazoles are one of the oldest and potent heterocyclic compounds having antimicrobial activities. 10, 11) Structure activity relationship studies of quinazolinone ring system revealed in various literatures [12] [13] [14] suggest position 2, 6 and 8 are very much important for structure activity studies and position 3 should be attached to different heterocyclic rings for better chemotherapeutic activity.
As these two heterocycles are present in biologically active compounds, we were interested in preparing compounds containing them. In view of these observations, we report herein the reactions of imidazoles with 2-chloro-N-(4-oxo-substituted-quinazolin-3(4H)-yl)-acetamides to give appropriate 2-(1H-substituted-imidazol-1-yl)-N-(4-oxo-substituted-quinazolin-3(4H)-yl)-acetamides 8-11ad and their antimicrobial activities.
Chemistry
In Chart 1, o-aminobenzoic acid was brominated at 15°C in presence of glacial acetic acid to form 2-amino-3,5-dibromobenzoic acid 1. Different anthranilic acids on treatment with benzoyl chloride/acid anhydrides yields substituted-4H-3,1-benzoxazin-4-one 2, 3ab, which on condensation with hydrazine hydrate gives 3-amino-substituted-quinazolin-4(3H)-one 4ab, 15, 16) 5a 17) and 5b. These 3-amino-quinazolin-4(3H)-ones 4, 5ab were reacted with chloroacetyl chloride in toluene to form 2-chloro-N-(4-oxo-substituted-quinazolin-3(4H)-yl)-acetamides 6, 7ab (compound 7a was reported as an intermediate for various quinazolin-4-one derivatives as anthelmintic agents, 7) which were later treated with imidazole derivatives in presence of anhydrous potassium carbonate to yield 2-(1H-substituted-imidazol-1-yl)-N-(4-oxo-substituted-quinazolin-3(4H)-yl)-acetamides 8-11ad. The infrared spectra of the 3-amino-quinazolin-4(3H)-ones 4, 5ab showed characteristic absorption bands at 3200-3300 cm Ϫ1 , was attributed to NH 2 , which were disappeared by the formation of 2-chloro-N-(4-oxo-substituted-quinazolin-3(4H)-yl)-acetamides 6, 7ab. Similarly the 1 H-NMR spectra of 2-chloro-N-(4-oxo-substituted-quinazolin-3(4H)-yl)-acetamides 6, 7ab showed characteristic diastereotopic two doublets at d 4.1-4.4 due to CϭOCH 2 Cl protons. Presence of singlet at d 6.6-7.3 due to imidazole protons established that all the 2-chloro-N-(4-oxo-substituted-quinazolin-3(4H)-yl)-acetamides had converted into 2-(1H-substituted-imidazol-1-yl)-N-(4-oxo-substituted-quinazolin-3(4H)-yl)-acetamides and 8-11ad. The 1 H-NMR, MS, IR and elemental analysis supported the structure of title compounds. Antitubercular Activity Compounds were evaluated for their in vitro antimycobacterial activity by agar dilution method 18) against Mycobacterium tuberculosis H 37 Rv and M. smegmatis in duplicate. The agar dilution method was performed using Middlebrook 7H10 medium supplemented with Middlebrook OADC medium (Hi-Media). After solidification of the agar, the plates were inoculated with 0.1 ml of 10 Ϫ4 dilutions of a McFarland 1.0 concentration of a suspension of organism. The inoculated plates were then incubated at 37°C for 4 weeks. The minimum inhibitory concentration (MIC) was considered to be the lowest concentration that completely inhibited growth on agar plates, disregarding a 3, 2007 single colony or a faint haze caused by the inoculums. In vitro antimycobacterial activity of tested compounds are reported in Table 1 .
Synthesis and Antimicrobial Activities of Some Novel Substituted 2-Imidazolyl-N-(4-oxo-quinazolin-3(4H)-yl)-acetamides
Antibacterial and Antifungal Activity The antibacterial and antifungal activity of title compounds was determined in vitro by using paper disc method. 19) The agar media for each microorganism were prepared as per by Institute of Microbial Technology, Chandigarh, India. The zone of inhibition (ZI) in mm was measured. The concentration (100 mg/ml) of test compounds were prepared by dissolving the compounds in dimethyl sulfoxide (DMSO). Under identical conditions, ciprofloxacin and griseofulvin were tested as standard drug (100 mg/ml) for bacteria and fungi respectively. Antibacterial and antifungal activity shown by moderately active compounds towards various bacteria is recorded in Table 2 .
Results and Discussion
In (Table 2) ; 9c was found to have similar activity against P. aeruginosa and K. pneumoniae also. Compounds 8ac, 9d and 11b showed moderate activity against C. tropicalis, P. aeruginosa and K. pneumoniae respectively. Compounds 8ac, 9ab and 10c were mild in activity against P. aeruginosa. 8bc, 9d, 10a and 11cd were mild in activity against K. pneumoniae. Compounds 9cd, 10d and 11bc showed mild activity against B. subtilis. As noted, against A. oryzae compounds 9d and 11b exhibit mild activity. However, the activities of the tested compounds are much less than those of standard antifungal and antibacterial agents used.
Structure activity relationship studies of the title compounds for antitubercular activity against M. tuberculosis indicates compound 9b (MIC, 0.4 mg/ml) having phenyl group at position 2 of the quinazolinone ring is more active than propyl derivative compound 11b (MIC, 6.25 mg/ml) and methyl derivative compound 10b (MIC, 6.25 mg/ml). Methyl substituted azoles attached to acetamido side chain at position 3 of quinazolinone proves more beneficial than unsubstituted azoles as compound 8b (MIC, 1.56 mg/ml), 11c (MIC, 1.56 mg/ml) are more active than compound 8a (MIC, Ͼ12.5 mg/ml) and 11a (MIC, Ͼ12.5 mg/ml) respectively. Replacement of hydrogen by bromine at position 6 and 8 of the quinazolinone ring as in compound 9b (MIC, 0.4 mg/ml) favors antitubercular activity than non halogen derivative compound 8b (MIC, 1.56 mg/ml).
Structured activity relationship studies for antibacterial and antifungal studies reveals that the presence of bromine at position 6 and 8 of the quinazolinone ring favors antifungal activity as compound 9a (ZI, 12.5 mm) is more active than compound 8a (ZI, 0 mm) against C. albicans; based on the same structural features compound 9c (ZI, 11 mm) is more active than 8c (ZI, 8.5 mm) against P. aeruginosa. On the other hand, in case of C. tropicalis it is the presence of bromine atom at position 6 and 8 of quinazolinone ring decreases activity as compound 9c (ZI, 0 mm) is inactive compared to moderately active compound 8c (ZI, 11 mm). As noted, methyl substituted azole moiety of 8b (ZI, 11.5 mm) increased activity against B. subtilis relative to 8a (ZI, 0 mm) that has unsubstituted azole; similarly compound 10b (ZI, 12 mm) is more active than compound 10a (ZI, 0 mm).
In summary, in view of these observations, we conclude that this series could be developed as a novel class of antimycobacterial agents. However, further structural evaluation is required to identify the potent molecule among the series.
Experimental
All the chemicals were purchased from Merck and used without purification. Analytical TLC was performed on Silica Gel F 254 plates (Merck) with visualization by UV light. Melting points were determined in open capillaries on a Thermonik melting point apparatus, Mumbai, India and are uncorrected. The IR spectra (KBr, gMax, cm
Ϫ1
) were run on Shimadzu-8400 FTIR spectrophotometer.
1 H-NMR (d ppm, CDCl 3 /DMSO-d 6 ) spectra were recorded using Brucker WM-400 spectrometer with TMS as internal standard. Mass spectra were recorded on Micromass Q-TOF and Shimadzu LCMS 2010A Mass spectrometer. Elemental analyses were performed on Thermo Finnigan FLASH EA 1122 CHNS Analyzer and were within Ϯ0.4% of theoretical values.
Synthesis of Substituted-4H-3,1-benzoxazin-4-one (2, 3)ab These compounds were synthesized by methods reported earlier. [20] [21] [22] General Method for the Synthesis of 2,6,8-Substituted-3-amino-4-oxoquinazolin-3(4H)-one (4, 5ab) Respective benzoxazin-4-ones (2, 3ab) (1.0 mmol) was refluxed with hydrazine hydrate (50 ml) for 3 h with occasional shaking. The reaction mixture was cooled to room temperature. The crystals formed were filtered, washed with water and dried. The products thus formed was recrystallized from ethyl acetate and used in the next step. 5) ab (1.8 mmol) was dissolved in 50 ml of dry toluene and cooled to 15°C. To this chloroacetyl chloride (2 mmol, 2.3 ml) was added drop wise with stirring. The temperature was brought slowly to room temperature and then refluxed for 4 h. Excess toluene was distilled off; precipitate obtained was filtered, washed several times with dry benzene, dried and recrystallized from aqueous dioxan. The completion of the reaction was monitored on silica gel 60 F 254 precoated TLC plates by using ethyl acetate, petroleum ether and methanol (1 : 1 : 0.3) as the eluent and observed in UV light. , 7ab) (0.6 mmol) was dissolved in 50 ml of dry toluene, to this freshly dried anhydrous potassium carbonate (0.65 mmol, 0.9 g) and substituted imidazole (0.67 mmol) were added and refluxed for 4-5 h. Excess toluene was distilled off; precipitate obtained was washed with petroleum ether, hot water, dried and recrystallized from aqueous dioxan. The completion of the reaction was monitored on silica gel 60 F 254 precoated TLC plates by using ethyl acetate, petroleum ether and methanol (1 : 1 : 0.3) as the eluent and observed in UV light. Imidazol-1-yl)-N-(4-oxo-2-phenyl-quinazolin-3(4H)-yl) -1H-imidazol-1-yl)-N-(4-oxo-2-phenyl-quinazolin-3(4H) -imidazol-1-yl)-N-(2,6,8-substituted-4-oxo-quinazolin-3(4H)-yl) -acetamide (9ad) 2-Chloro-N-(6,8-dibromo-4-oxo-2-phenyl-quinazolin-3(4H)-yl)-acetamide (6b), (0.6 mmol) was dissolved in 50 ml of dry dioxan, to this freshly dried anhydrous potassium carbonate (0.65 mmol, 0.9 g) and different imidazoles (0.67 mmol) were added and refluxed for 4 h. Excess dioxan was distilled off; precipitate obtained was washed with hot water, dried and recrystallized from aqueous dioxan. The completion of the reaction was monitored on silica gel 60 F 254 precoated TLC plates by using ethyl acetate, petroleum ether and methanol (1 : 
General Method for the Synthesis of 2-Chloro-N-(2,6,8-substituted-4-oxo-quinazolin-3(4H)-yl)-acetamide (6, 7)ab 2,6,8-Substituted-3-amino-4-oxoquinazolin-3(4H)-one (4,

2-Chloro-N-(4-oxo-2-phenyl-quinazolin-3(4H)-yl)-acetamide (6a)
Yield
2-(1H-
